|
1
|
Yigit S, Pehlivan FS, Evcim G and Etit D:
Clinicopathologic features of the mixed epithelial and mesenchymal
type metaplastic breast carcinoma with myoepithelial
differentiation in a subset of six cases. Pathol Res Pract.
208:147–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Velasco M, Santamaría G, Ganau S, Farrús
B, Zanón G, Romagosa C and Fernández PL: MRI of metaplastic
carcinoma of the breast. AJR Am J Roentgenol. 184:1274–1278. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Al Sayed AD, El Weshi AN, Tulbah AM, Rahal
MM and Ezzat AA: Metaplastic carcinoma of the breast clinical
presentation, treatment results and prognostic factors. Acta Oncol.
45:188–195. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lien HC, Hsiao YH, Lin YS, Yao YT, Juan
HF, Kuo WH, Hung MC, Chang KJ and Hsieh FJ: Molecular signatures of
metaplastic carcinoma of the breast by large-scale transcriptional
profiling: Identification of genes potentially related to
epithelial-mesenchymal transition. Oncogene. 26:7859–7871. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, Toy KA and Kleer CG: Metaplastic
breast carcinomas are enriched in markers of tumor-initiating cells
and epithelial to mesenchymal transition. Mod Pathol. 25:178–184.
2012.PubMed/NCBI
|
|
6
|
Langlands F, Cornford E, Rakha E, Dall B,
Gutteridge E, Dodwell D, Shaaban AM and Sharma N: Imaging overview
of metaplastic carcinomas of the breast: A large study of 71 cases.
Br J Radiol. Jun 21–2016.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sherwell-Cabello S, Maffuz-Aziz A,
Hernández-Hernández B, Bautista-Piña V, Labastida-Almendaro S and
Rodríguez-Cuevas S: Metaplastic carcinoma of the breast and the
impact of the p63 and cytokeratin 5/6: Experience of 40 patients.
Ginecol Obstet Mex. 84:127–135. 2016.(In Spanish). PubMed/NCBI
|
|
8
|
Grechi G and Pagnini P: Study of mammary
gland neoplasms with an osteocartilaginous component. I.
Cartilaginous metaplastic epiphenomena in the course of connective
tissue malignancy. Arch De Vecchi Anat Patol. 46:277–303. 1965.(In
Italian).
|
|
9
|
Gibson GR, Qian D, Ku JK and Lai LL:
Metaplastic breast cancer: Clinical features and outcomes. Am Surg.
71:725–730. 2005.PubMed/NCBI
|
|
10
|
Chao TC, Wang CS, Chen SC and Chen MF:
Metaplastic carcinomas of the breast. J Surg Oncol. 71:220–225.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jung SY, Kim HY, Nam BH, Min SY, Lee SJ,
Park C, Kwon Y, Kim EA, Ko KL, Shin KH, et al: Worse prognosis of
metaplastic breast cancer patients than other patients with
triple-negative breast cancer. Breast Cancer Res Treat.
120:627–637. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nelson RA, Guye ML, Luu T and Lai LL:
Survival outcomes of metaplastic breast cancer patients: Results
from a US population-based analysis. Ann Surg Oncol. 22:24–31.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Beatty JD, Atwood M, Tickman R and Reiner
M: Metaplastic breast cancer: Clinical significance. Am J Surg.
191:657–664. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pezzi CM, Patel-Parekh L, Cole K, Franko
J, Klimberg VS and Bland K: Characteristics and treatment of
metaplastic breast cancer: Analysis of 892 cases from the National
Cancer Data Base. Ann Surg Oncol. 14:166–173. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shah DR, Tseng WH and Martinez SR:
Treatment options for metaplastic breast cancer. ISRN Oncol.
2012:7061622012.PubMed/NCBI
|
|
16
|
Frank GA, Danilova NV, Andreeva Iulu and
Nefedova NA: WHO classification of tumors of the breast, 2012. Arkh
Patol. 75:53–63. 2013.(In Russian). PubMed/NCBI
|
|
17
|
Sinn HP, Helmchen B and Wittekind CH: TNM
classification of breast cancer: Changes and comments on the 7th
edition. Pathologe. 31:361–366. 2010.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okada N, Hasebe T, Iwasaki M, Tamura N,
Akashi-Tanaka S, Hojo T, Shibata T, Sasajima Y, Kanai Y and
Kinoshita T: Metaplastic carcinoma of the breast. Hum Pathol.
41:960–970. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamaguchi R, Horii R, Maeda I, Suga S,
Makita M, Iwase T, Oguchi M, Ito Y and Akiyama F: Clinicopathologic
study of 53 metaplastic breast carcinomas: Their elements and
prognostic implications. Hum Pathol. 41:679–685. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choi BB and Shu KS: Metaplastic carcinoma
of the breast: Multimodality imaging and histopathologic
assessment. Acta Radiol. 53:5–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oberman HA: Metaplastic carcinoma of the
breast. A clinicopathologic study of 29 patients. Am J Surg Pathol.
11:918–929. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dave G, Cosmatos H, Do T, Lodin K and
Varshney D: Metaplastic carcinoma of the breast: A retrospective
review. Int J Radiat Oncol Biol Phys. 64:771–775. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park HS, Park S, Kim JH, Lee JH, Choi SY,
Park BW and Lee KS: Clinicopathologic features and outcomes of
metaplastic breast carcinoma: Comparison with invasive ductal
carcinoma of the breast. Yonsei Med J. 51:864–869. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bae SY, Lee SK, Koo MY, Hur SM, Choi MY,
Cho DH, Kim S, Choe JH, Lee JE, Kim JH, et al: The prognoses of
metaplastic breast cancer patients compared to those of
triple-negative breast cancer patients. Breast Cancer Res Treat.
126:471–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee H, Jung SY, Ro JY, Kwon Y, Sohn JH,
Park IH, Lee KS, Lee S, Kim SW, Kang HS, et al: Metaplastic breast
cancer: Clinicopathological features and its prognosis. J Clin
Pathol. 65:441–446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cakir A, Gönül II and Uluoğlu O:
Metaplastic breast carcinomas and their relationship with
basal-like phenotype. Turk Patoloji Derg. 28:134–141.
2012.PubMed/NCBI
|
|
27
|
Wright G Paul, Davis AT, Koehler TJ,
Melnik MK and Chung MH: Hormone receptor status does not affect
prognosis in metaplastic breast cancer: A population-based analysis
with comparison to infiltrating ductal and lobular carcinomas. Ann
Surg Oncol. 21:3497–3503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hennessy BT, Giordano S, Broglio K, Duan
Z, Trent J, Buchholz TA, Babiera G, Hortobagyi GN and Valero V:
Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann
Oncol. 17:605–613. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takuwa H, Ueno T, Ishiguro H, Mikami Y,
Kanao S, Takada M, Sugie T and Toi M: A case of metaplastic breast
cancer that showed a good response to platinum-based preoperative
chemotherapy. Breast Cancer. 21:504–507. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rayson D, Adjei AA, Suman VJ, Wold LE and
Ingle JN: Metaplastic breast cancer: Prognosis and response to
systemic therapy. Ann Oncol. 10:413–419. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moulder S, Moroney J, Helgason T, Wheler
J, Booser D, Albarracin C, Morrow PK, Koenig K and Kurzrock R:
Responses to liposomal doxorubicin, bevacizumab, and temsirolimus
in metaplastic carcinoma of the breast: Biologic rationale and
implications for stem-cell research in breast cancer. J Clin Oncol.
29:e572–575. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen IC, Lin CH, Huang CS, Lien HC, Hsu C,
Kuo WH, Lu YS and Cheng AL: Lack of efficacy to systemic
chemotherapy for treatment of metaplastic carcinoma of the breast
in the modern era. Breast Cancer Res Treat. 130:345–351. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lakhani SR, Reis-Filho JS, Fulford L,
Penault-Llorca F, van der Vijver M, Parry S, Bishop T, Benitez J,
Rivas C, Bignon YJ, et al: Prediction of BRCA1 status in patients
with breast cancer using estrogen receptor and basal phenotype.
Clin Cancer Res. 11:5175–5180. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Foulkes WD, Stefansson IM, Chappuis PO,
Bégin LR, Goffin JR, Wong N, Trudel M and Akslen LA: Germline BRCA1
mutations and a basal epithelial phenotype in breast cancer. J Natl
Cancer Inst. 95:1482–1485. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Banerjee S, Reis-Filho JS, Ashley S,
Steele D, Ashworth A, Lakhani SR and Smith IE: Basal-like breast
carcinomas: Clinical outcome and response to chemotherapy. J Clin
Pathol. 59:729–735. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ashworth A: A synthetic lethal therapeutic
approach: Poly(ADP) ribose polymerase inhibitors for the treatment
of cancers deficient in DNA double-strand break repair. J Clin
Oncol. 26:3785–3790. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Colleoni M, Cole BF, Viale G, Regan MM,
Price KN, Maiorano E, Mastropasqua MG, Crivellari D, Gelber RD,
Goldhirsch A, et al: Classical cyclophosphamide, methotrexate, and
fluorouracil chemotherapy is more effective in triple-negative,
node-negative breast cancer: Results from two randomized trials of
adjuvant chemoendocrine therapy for node-negative breast cancer. J
Clin Oncol. 28:2966–2973. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tseng WH and Martinez SR: Metaplastic
breast cancer: To radiate or not to radiate? Ann Surg Oncol.
18:94–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Weigelt B, Kreike B and Reis-Filho JS:
Metaplastic breast carcinomas are basal-like breast cancers: A
genomic profiling analysis. Breast Cancer Res Treat. 117:273–280.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Luini A, Aguilar M, Gatti G, Fasani R,
Botteri E, Brito JA, Maisonneuve P, Vento AR and Viale G:
Metaplastic carcinoma of the breast, an unusual disease with worse
prognosis: The experience of the European institute of oncology and
review of the literature. Breast Cancer Res Treat. 101:349–353.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lim KH, Oh DY, Chie EK, Han W, Im SA, Kim
TY, Park IA, Noh DY, Ha SW and Bang YJ: Metaplastic breast
carcinoma: Clinicopathologic features and prognostic value of
triple negativity. Jpn J Clin Oncol. 40:112–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hu Q, Chen WX, Zhong SL, Li J, Luo Z, Tang
JH and Zhao JH: Current progress in the treatment of metaplastic
breast carcinoma. Asian Pac J Cancer Prev. 14:6221–6225. 2013.
View Article : Google Scholar : PubMed/NCBI
|
